-
1
-
-
0028343115
-
Vascular endothelial growth factor as capillary permeability agent in ovarian hyper stimulation syndrome
-
N. Mc Clure, D.L. Healy, and P.A. Rogers Vascular endothelial growth factor as capillary permeability agent in ovarian hyper stimulation syndrome Lancet 344 1994 235 236
-
(1994)
Lancet
, vol.344
, pp. 235-236
-
-
Mc Clure, N.1
Healy, D.L.2
Rogers, P.A.3
-
2
-
-
0342618534
-
Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization
-
A. Lee, L.K. Christenson, and P.E. Stouffer Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization Fertil Steril 68 1997 305 311
-
(1997)
Fertil Steril
, vol.68
, pp. 305-311
-
-
Lee, A.1
Christenson, L.K.2
Stouffer, P.E.3
-
3
-
-
0036328484
-
Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of Vascular Endothelial Growth Factor
-
T.H. Wang, S.G. Horng, and C.L. Chang Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of Vascular Endothelial Growth Factor J Clin Endocrinol Metab 87 2002 3300 3308
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3300-3308
-
-
Wang, T.H.1
Horng, S.G.2
Chang, C.L.3
-
4
-
-
0036827816
-
Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats and this effect is prevented by receptor blockade
-
R. Gomez, C. Simon, and J. Remoti Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats and this effect is prevented by receptor blockade Endocrinology 143 2002 4339 4348
-
(2002)
Endocrinology
, vol.143
, pp. 4339-4348
-
-
Gomez, R.1
Simon, C.2
Remoti, J.3
-
5
-
-
0035026748
-
The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor
-
S. Basu, J.A. Nagy, and S. Pal The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor Nat Med 7 2001 569 574
-
(2001)
Nat Med
, vol.7
, pp. 569-574
-
-
Basu, S.1
Nagy, J.A.2
Pal, S.3
-
6
-
-
4744348385
-
Dopamine in vivo inhibits VEGF-induced Phophotylation of VEGFR-2, MAPK and focal adhesion kinase in endothelial cell
-
C. Sarkar, D. Chakroboty, and R.B. Mitra Dopamine in vivo inhibits VEGF-induced Phophotylation of VEGFR-2, MAPK and focal adhesion kinase in endothelial cell Am J Physiol Heart Circ Physiol 287 2004 H1554 H1560
-
(2004)
Am J Physiol Heart Circ Physiol
, vol.287
-
-
Sarkar, C.1
Chakroboty, D.2
Mitra, R.B.3
-
7
-
-
0026596908
-
Dopamine treatment for severe hyperstimulation syndrome
-
A.P. Ferraretti, L. Gianaroli, and L. Diotallevi Dopamine treatment for severe hyperstimulation syndrome Hum Reprod 7 1992 180 183
-
(1992)
Hum Reprod
, vol.7
, pp. 180-183
-
-
Ferraretti, A.P.1
Gianaroli, L.2
Diotallevi, L.3
-
9
-
-
0042834004
-
Treatment for ovarian hyperstimulation syndrome using oral dopamine prodrug docarpamine
-
T. Tsunoda, H. Shibahara, and Y. Hirano Treatment for ovarian hyperstimulation syndrome using oral dopamine prodrug docarpamine Gynecol Endocrinol 17 2003 281 286
-
(2003)
Gynecol Endocrinol
, vol.17
, pp. 281-286
-
-
Tsunoda, T.1
Shibahara, H.2
Hirano, Y.3
-
10
-
-
0035157012
-
Cabergoline influences ovarian hyperstimulation in hyperprolactinemic patients with polycystic ovary sindrome
-
E. Papaleo, N. Doldi, and L. De Santis Cabergoline influences ovarian hyperstimulation in hyperprolactinemic patients with polycystic ovary sindrome Hum Reprod 16 2001 2263 2266
-
(2001)
Hum Reprod
, vol.16
, pp. 2263-2266
-
-
Papaleo, E.1
Doldi, N.2
De Santis, L.3
|